244 related articles for article (PubMed ID: 4175472)
1. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
McKenzie JM; McCullagh EP
J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
[No Abstract] [Full Text] [Related]
2. L.A.T.S. and Graves' disease.
Hedley AJ; Ross IP; Crooks J
Lancet; 1970 Aug; 2(7670):468-9. PubMed ID: 4195146
[No Abstract] [Full Text] [Related]
3. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
[No Abstract] [Full Text] [Related]
4. The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.
Martin FI; Larkins RG; Alford FP; Andrews JT; Greenberg PB; Melick RA; Penington JS
Aust N Z J Med; 1972 May; 2(2):168-72. PubMed ID: 4116447
[No Abstract] [Full Text] [Related]
5. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
McKenzie JM
Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
[No Abstract] [Full Text] [Related]
6. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
Busnardo B; Accordi F; Debiasi S
Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
[No Abstract] [Full Text] [Related]
7. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
8. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
[No Abstract] [Full Text] [Related]
9. Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct.
Gharib H; Mayberry WE
Mayo Clin Proc; 1970 Jun; 45(6):444-9. PubMed ID: 4193249
[No Abstract] [Full Text] [Related]
10. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
McKenzie JM; Zakarija M; D'Amour P; Joasoo A
N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
[No Abstract] [Full Text] [Related]
11. Studies on the pathogenesis of the ophthalmopathy of Graves' disease.
Kriss JP; Pleshakov V; Rosenblum AL; Holderness M; Sharp G; Utiger R
J Clin Endocrinol Metab; 1967 Apr; 27(4):582-93. PubMed ID: 6071430
[No Abstract] [Full Text] [Related]
12. [Clinical studies of long-acting thyroid stimulator].
Eguchi Y
Nihon Naibunpi Gakkai Zasshi; 1970 Nov; 46(8):939-52. PubMed ID: 4099204
[No Abstract] [Full Text] [Related]
13. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
[No Abstract] [Full Text] [Related]
14. [Hyperthyroidism and the "long acting thyroid stimulator" (LATS)].
Studer H
Schweiz Med Wochenschr; 1967 May; 97(19):622-3. PubMed ID: 5632362
[No Abstract] [Full Text] [Related]
15. [LATS in Graves-Basedow disease].
Nauman J; Nauman A
Pol Arch Med Wewn; 1971; 46(3):315-21. PubMed ID: 5108058
[No Abstract] [Full Text] [Related]
16. Long-acting thyroid stimulator in Graves' disease.
Sellers EA; Awad AG; Schönbaum E
Lancet; 1970 Aug; 2(7668):335-8. PubMed ID: 4194442
[No Abstract] [Full Text] [Related]
17. Familial incidence of long-acting thyroid stimulator (LATS) in Graves' disease.
Bonnyns M; Vanhaelst L
Horm Metab Res; 1972 Mar; 4(2):132. PubMed ID: 5067566
[No Abstract] [Full Text] [Related]
18. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
Lamberg BA; Gordin A
Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
[No Abstract] [Full Text] [Related]
19. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
Földes J; Krasznai I; Piroska E; Gesztesi E; Takács I
Endokrinologie; 1967; 52(1):80-7. PubMed ID: 4171706
[No Abstract] [Full Text] [Related]
20. Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.
Lamberg BA; Gordin A; Viherkoski M; Kvist G
Acta Endocrinol (Copenh); 1969 Oct; 62(2):199-209. PubMed ID: 5394703
[No Abstract] [Full Text] [Related]
[Next] [New Search]
